Summary by Futu AI
JD Health held its annual shareholder meeting on June 21, 2024, during which all proposed resolutions were approved. The company has issued a total of 3,189,465,111 shares, of which 47,290,140 shares of unattributed award shares are held by a trustee and waived voting rights. The total number of valid voting shares is 3,142,174,971. The meeting passed resolutions including the acceptance and adoption of the audited consolidated financial statements for the fiscal year 2023, the director and auditor's report, and the reelection of Ms. Li Ling, Dr. Zhang Jiyu, and Mr. Chen Xingyao as independent non-executive directors. In addition, the board of directors was authorized to determine director remuneration, reappoint Deloitte as auditor, and grant general authority to directors for the issuance, offering, and handling...Show More